Compounds > histamine
Page last updated: 2024-10-18

histamine and Breast Cancer

histamine has been researched along with Breast Cancer in 44 studies

Research Excerpts

ExcerptRelevanceReference
" While cimetidine, an H2 antagonist, has been shown to influence the presence of tumour infiltrating lymphocytes (TIL) in colorectal cancer (Adams and Morris, 1994, 1997) that was not found to be the case in breast cancer (Ng et al, 1995)."9.09Histamine, mast cells and tumour cell proliferation in breast cancer: does preoperative cimetidine administration have an effect? ( Bolton, E; Bowrey, PF; King, J; Magarey, C; Marr, P; Morris, DL; Schwartz, P, 2000)
"The main focus of our study is to assess the anti-cancer activity of cimetidine and vitamin C via combating the tumor supportive role of mast cell mediators (histamine, VEGF, and TNF-α) within the tumor microenvironment and their effect on the protein kinase A(PKA)/insulin receptor substrate-1(IRS-1)/phosphatidylinositol-3-kinase (PI3K)/serine/threonine kinase-1 (AKT)/mammalian target of rapamycin (mTOR) cue in Ehrlich induced breast cancer in mice."8.12Anti-neoplastic action of Cimetidine/Vitamin C on histamine and the PI3K/AKT/mTOR pathway in Ehrlich breast cancer. ( Achy, SE; El-Aal, SAA; Ibrahim, SSA; Reda, AM; Shahine, Y, 2022)
"The aim of this work was to improve the knowledge of the role of histamine in breast cancer by assessing the therapeutic efficacy of histamine and histamine H4 receptor (H4R) ligands in a triple-negative breast cancer (TNBC) model developed in immunocompetent hosts."7.96Study of the antitumour effects and the modulation of immune response by histamine in breast cancer. ( Cremaschi, GA; Formoso, K; Herrero Ducloux, MV; Martinel Lamas, D; Massari, NA; Medina, VA; Nicoud, MB; Sterle, HA; Táquez Delgado, MA, 2020)
"A novel biomimetic drug delivery system (BDDS) inspired by the pH-dependent ferric ion-transport and release manner of transferrin (Tf) was developed for combating multidrug-resistant breast cancer."7.85Transferrin-inspired vehicles based on pH-responsive coordination bond to combat multidrug-resistant breast cancer. ( Cui, PF; He, YJ; Jiang, HL; Lu, N; Luo, CQ; Lyu, JY; Qiao, JB; Xing, L; Zhang, JL; Zhang, M; Zhou, YX; Zhu, Y, 2017)
"The aim of the study was to evaluate histamine concentrations in plasma and tissues of breast cancers depending on the activity of histamine metabolic enzymes in neoplasmatic tissues of the breast gland."7.75Histamine and its metabolizing enzymes in tissues of primary ductal breast cancer. ( Sieja, K; Stanosz, M; Stanosz, S; von Mach-Szczypiński, J, 2009)
"The aim of this study was to evaluate the concentration of histamine (HA) and the activities of their enzymes, namely histidine decarboxylase (HDC) and diaminooxydase (DAO) in 95 women with ductal breast cancer and in healthy women."7.73Concentration of histamine in serum and tissues of the primary ductal breast cancers in women. ( Olewniczak, S; Sieja, K; Stanosz, M; Stanosz, S; von Mach-Szczypiński, J, 2005)
"Tumour and adjacent normal breast content of histamine was measured using a radioenzymatic assay in 29 patients having surgery for breast cancer."7.70Histamine in human breast cancer. ( Adams, WJ; Akhter, JA; Magarey, CJ; Morris, DL; Reynolds, JL; Schwartz, P, 1998)
"The present study in 10 breast cancer patients supports the concept that newly synthetized, nascent histamine is involved in tumour growth."7.67Changes in histamine synthesis, tissue content and catabolism in human breast cancer. ( Garcia-Caballero, M; Heredia, A; Neugebauer, E; Nuñez de Castro, I; Oosting, E; Rodriguez, F; Vara Thorbeck, C, 1989)
"In view of the controversy that exists regarding the histamine content and diamine oxidase activity in relation to human carcinomatous growths, the present investigation was undertaken and carcinomatous tissues of skin, breast and rectum were analysed."7.67Diamineoxidase activity and tissue histamine content of human skin, breast and rectal carcinoma. ( Chanda, R; Ganguly, AK, 1987)
"It is established that histamine in the concentration of 10(-4)-10(-5) M possesses an inhibitory effect in the lymphocyte adherence inhibition test in patients with breast cancer."7.67[Histamine-receptor sensitivity of lymphocytes in patients with early and advanced stage breast cancer]. ( Kharkevich, DD; Polevaia, EB, 1988)
"Histamine concentration in breast cancer tissues was found to be higher than that in normal tissues of healthy controls by means of an increase in the activity of histidine decarboxylase (HDC), the enzyme involved in histamine production."6.52Histamine H4 receptor: insights into a potential therapeutic target in breast cancer. ( Martinel Lamas, DJ; Medina, VA; Rivera, ES, 2015)
"Notably, pre-treatment of breast cancer cells with 20μM histamine prevented the mesenchymal changes induced by ionizing radiation and also reduced the migratory behavior of irradiated cells decreasing phospho-Src levels."5.43Histamine prevents radiation-induced mesenchymal changes in breast cancer cells. ( Bergoc, RM; Crescenti, EJ; Cricco, GP; Galarza, TE; Martín, GA; Mohamad, NA; Táquez Delgado, MA; Vedoya, GM, 2016)
"Histamine was able also to potentiate in vivo the anti-tumoral effect of radiation, increasing the exponential tumor doubling time."5.42Enhancement of ionizing radiation response by histamine in vitro and in vivo in human breast cancer. ( Balestrasse, KB; Blanco, H; Cortina, JE; Cremaschi, GA; Martinel Lamas, DJ; Medina, VA; Rivera, ES; Sterle, HA; Valli, E; Ventura, C, 2015)
" While cimetidine, an H2 antagonist, has been shown to influence the presence of tumour infiltrating lymphocytes (TIL) in colorectal cancer (Adams and Morris, 1994, 1997) that was not found to be the case in breast cancer (Ng et al, 1995)."5.09Histamine, mast cells and tumour cell proliferation in breast cancer: does preoperative cimetidine administration have an effect? ( Bolton, E; Bowrey, PF; King, J; Magarey, C; Marr, P; Morris, DL; Schwartz, P, 2000)
"The main focus of our study is to assess the anti-cancer activity of cimetidine and vitamin C via combating the tumor supportive role of mast cell mediators (histamine, VEGF, and TNF-α) within the tumor microenvironment and their effect on the protein kinase A(PKA)/insulin receptor substrate-1(IRS-1)/phosphatidylinositol-3-kinase (PI3K)/serine/threonine kinase-1 (AKT)/mammalian target of rapamycin (mTOR) cue in Ehrlich induced breast cancer in mice."4.12Anti-neoplastic action of Cimetidine/Vitamin C on histamine and the PI3K/AKT/mTOR pathway in Ehrlich breast cancer. ( Achy, SE; El-Aal, SAA; Ibrahim, SSA; Reda, AM; Shahine, Y, 2022)
"The aim of this work was to improve the knowledge of the role of histamine in breast cancer by assessing the therapeutic efficacy of histamine and histamine H4 receptor (H4R) ligands in a triple-negative breast cancer (TNBC) model developed in immunocompetent hosts."3.96Study of the antitumour effects and the modulation of immune response by histamine in breast cancer. ( Cremaschi, GA; Formoso, K; Herrero Ducloux, MV; Martinel Lamas, D; Massari, NA; Medina, VA; Nicoud, MB; Sterle, HA; Táquez Delgado, MA, 2020)
"A novel biomimetic drug delivery system (BDDS) inspired by the pH-dependent ferric ion-transport and release manner of transferrin (Tf) was developed for combating multidrug-resistant breast cancer."3.85Transferrin-inspired vehicles based on pH-responsive coordination bond to combat multidrug-resistant breast cancer. ( Cui, PF; He, YJ; Jiang, HL; Lu, N; Luo, CQ; Lyu, JY; Qiao, JB; Xing, L; Zhang, JL; Zhang, M; Zhou, YX; Zhu, Y, 2017)
"The aim of the study was to evaluate histamine concentrations in plasma and tissues of breast cancers depending on the activity of histamine metabolic enzymes in neoplasmatic tissues of the breast gland."3.75Histamine and its metabolizing enzymes in tissues of primary ductal breast cancer. ( Sieja, K; Stanosz, M; Stanosz, S; von Mach-Szczypiński, J, 2009)
"The aim of this study was to evaluate the concentration of histamine (HA) and the activities of their enzymes, namely histidine decarboxylase (HDC) and diaminooxydase (DAO) in 95 women with ductal breast cancer and in healthy women."3.73Concentration of histamine in serum and tissues of the primary ductal breast cancers in women. ( Olewniczak, S; Sieja, K; Stanosz, M; Stanosz, S; von Mach-Szczypiński, J, 2005)
"Tumour and adjacent normal breast content of histamine was measured using a radioenzymatic assay in 29 patients having surgery for breast cancer."3.70Histamine in human breast cancer. ( Adams, WJ; Akhter, JA; Magarey, CJ; Morris, DL; Reynolds, JL; Schwartz, P, 1998)
"We studied 100 patients: 40 with breast cancer, 41 with benign breast tumours and 19 non-cancer-bearing cholecystectomy patients, in order to measure the histidine decarboxylase activity and histamine content in benign and malignant breast tumours, and to determine whether the histamine metabolism affected skin and muscle tissue distant from the tumour."3.69Histamine synthesis and content in benign and malignant breast tumours. Its effects on other host tissues. ( Garcia-Caballero, M; Neugebauer, E; Nuñez de Castro, I; Rodriguez, F; Vara-Thorbeck, C, 1994)
"The present study in 10 breast cancer patients supports the concept that newly synthetized, nascent histamine is involved in tumour growth."3.67Changes in histamine synthesis, tissue content and catabolism in human breast cancer. ( Garcia-Caballero, M; Heredia, A; Neugebauer, E; Nuñez de Castro, I; Oosting, E; Rodriguez, F; Vara Thorbeck, C, 1989)
"In view of the controversy that exists regarding the histamine content and diamine oxidase activity in relation to human carcinomatous growths, the present investigation was undertaken and carcinomatous tissues of skin, breast and rectum were analysed."3.67Diamineoxidase activity and tissue histamine content of human skin, breast and rectal carcinoma. ( Chanda, R; Ganguly, AK, 1987)
"It is established that histamine in the concentration of 10(-4)-10(-5) M possesses an inhibitory effect in the lymphocyte adherence inhibition test in patients with breast cancer."3.67[Histamine-receptor sensitivity of lymphocytes in patients with early and advanced stage breast cancer]. ( Kharkevich, DD; Polevaia, EB, 1988)
"Particularly, in breast cancer, their function is still under discussion."2.58Mast Cell, the Neglected Member of the Tumor Microenvironment: Role in Breast Cancer. ( Aponte-López, A; Cortes-Muñoz, D; Fuentes-Pananá, EM; Muñoz-Cruz, S, 2018)
"Histamine concentration in breast cancer tissues was found to be higher than that in normal tissues of healthy controls by means of an increase in the activity of histidine decarboxylase (HDC), the enzyme involved in histamine production."2.52Histamine H4 receptor: insights into a potential therapeutic target in breast cancer. ( Martinel Lamas, DJ; Medina, VA; Rivera, ES, 2015)
"One fourth of early-stage breast cancer cases become metastatic during the follow-up period."1.72Intervention for Hepatic and Pulmonary Metastases in Breast Cancer Patients: Prospective, Multi-institutional Registry Study-IMET, Protocol MF 14-02. ( Aytac, O; Dag, A; Dalci, K; Dogan, L; Dogan, M; Gokgoz, S; Isik, A; Karadeniz Cakmak, G; Karanlik, H; Ozbas, S; Ozcinar, B; Ozyar, E; Senol, K; Sezer, YA; Sezgin, E; Soran, A, 2022)
"In the present study, exposure of MCF-7 breast cancer cells to HIS and the H1 receptor antagonist AST both alone and together with HIS (AST-HIS) led to generation of intracellular ROS, which induced massive cellular vacuolization through dilation of the ER and mitochondria."1.43Astemizole-Histamine induces Beclin-1-independent autophagy by targeting p53-dependent crosstalk between autophagy and apoptosis. ( Bhardwaj, M; Jakhar, R; Kang, SC; Paul, S, 2016)
"Notably, pre-treatment of breast cancer cells with 20μM histamine prevented the mesenchymal changes induced by ionizing radiation and also reduced the migratory behavior of irradiated cells decreasing phospho-Src levels."1.43Histamine prevents radiation-induced mesenchymal changes in breast cancer cells. ( Bergoc, RM; Crescenti, EJ; Cricco, GP; Galarza, TE; Martín, GA; Mohamad, NA; Táquez Delgado, MA; Vedoya, GM, 2016)
"Histamine was able also to potentiate in vivo the anti-tumoral effect of radiation, increasing the exponential tumor doubling time."1.42Enhancement of ionizing radiation response by histamine in vitro and in vivo in human breast cancer. ( Balestrasse, KB; Blanco, H; Cortina, JE; Cremaschi, GA; Martinel Lamas, DJ; Medina, VA; Rivera, ES; Sterle, HA; Valli, E; Ventura, C, 2015)
"Histamine is a biogenic amine responsible for multiple biological actions including regulation of physiological functions of mammary gland."1.33Histamine-mediated signaling processes in human malignant mammary cells. ( Bergoc, R; Correa-Fiz, F; Cricco, G; Martín, G; Medina, V; Mohamad, N; Nuñez, M; Rivera, ES; Sanchez-Jimenez, F, 2006)
" They conclude that, as already suggested for others kinds of neoplasms of the lung and gastroenteric tract, also in the neoplastic pathology of the breast, the haematic hystamine dosage is a useful parameter for the monitoring the course of the illness."1.26[Hyperhistaminemia in neoplasms of the breast]. ( Faverio, F; Guzzetti, A; Jemoli, R; Mereghetti, A, 1982)

Research

Studies (44)

TimeframeStudies, this research(%)All Research%
pre-199014 (31.82)18.7374
1990's5 (11.36)18.2507
2000's10 (22.73)29.6817
2010's10 (22.73)24.3611
2020's5 (11.36)2.80

Authors

AuthorsStudies
Ibrahim, SSA1
El-Aal, SAA1
Reda, AM1
Achy, SE1
Shahine, Y1
Soran, A1
Ozbas, S1
Ozcinar, B1
Isik, A1
Dogan, L1
Senol, K1
Dag, A1
Karanlik, H1
Aytac, O1
Karadeniz Cakmak, G1
Dalci, K1
Dogan, M1
Sezer, YA1
Gokgoz, S1
Ozyar, E1
Sezgin, E1
Nicoud, MB3
Sterle, HA3
Massari, NA3
Táquez Delgado, MA3
Formoso, K1
Herrero Ducloux, MV1
Martinel Lamas, D1
Cremaschi, GA3
Medina, VA6
Halim, AA1
Alsayed, B1
Embarak, S1
Yaseen, T1
Dabbous, S1
Fontaine, O1
Dueluzeau, R1
Raibaud, P1
Chabanet, C1
Popoff, MR1
Badoual, J1
Gabilan, JC1
Andremont, A1
Gómez, L1
Andrés, S1
Sánchez, J1
Alonso, JM1
Rey, J1
López, F1
Jiménez, A1
Yan, Z1
Zhou, L1
Zhao, Y3
Wang, J6
Huang, L2
Hu, K1
Liu, H4
Wang, H3
Guo, Z1
Song, Y1
Huang, H4
Yang, R1
Owen, TW1
Al-Kaysi, RO1
Bardeen, CJ1
Cheng, Q1
Wu, S1
Cheng, T1
Zhou, X1
Wang, B4
Zhang, Q4
Wu, X2
Yao, Y3
Ochiai, T1
Ishiguro, H2
Nakano, R2
Kubota, Y2
Hara, M1
Sunada, K1
Hashimoto, K1
Kajioka, J1
Fujishima, A1
Jiao, J3
Gai, QY3
Wang, W2
Zang, YP2
Niu, LL2
Fu, YJ3
Wang, X4
Yao, LP1
Qin, QP1
Wang, ZY1
Liu, J4
Aleksic Sabo, V1
Knezevic, P1
Borges-Argáez, R1
Chan-Balan, R1
Cetina-Montejo, L1
Ayora-Talavera, G1
Sansores-Peraza, P1
Gómez-Carballo, J1
Cáceres-Farfán, M1
Jang, J1
Akin, D1
Bashir, R1
Yu, Z1
Zhu, J2
Jiang, H1
He, C2
Xiao, Z1
Xu, J2
Sun, Q1
Han, D1
Lei, H1
Zhao, K2
Zhu, L1
Li, X4
Fu, H2
Wilson, BK1
Step, DL1
Maxwell, CL1
Gifford, CA1
Richards, CJ1
Krehbiel, CR1
Warner, JM1
Doerr, AJ1
Erickson, GE1
Guretzky, JA1
Rasby, RJ1
Watson, AK1
Klopfenstein, TJ1
Sun, Y4
Liu, Z3
Pham, TD1
Lee, BK1
Yang, FC1
Wu, KH1
Lin, WP1
Hu, MK1
Lin, L3
Shao, J1
Sun, M1
Xu, G1
Zhang, X6
Xu, N1
Wang, R1
Liu, S1
He, H1
Dong, X2
Yang, M2
Yang, Q1
Duan, S1
Yu, Y2
Han, J2
Zhang, C3
Chen, L2
Yang, X1
Li, W3
Wang, T2
Campbell, DA1
Gao, K1
Zager, RA1
Johnson, ACM1
Guillem, A1
Keyser, J1
Singh, B1
Steubl, D1
Schneider, MP1
Meiselbach, H1
Nadal, J1
Schmid, MC1
Saritas, T1
Krane, V1
Sommerer, C1
Baid-Agrawal, S1
Voelkl, J1
Kotsis, F1
Köttgen, A1
Eckardt, KU1
Scherberich, JE1
Li, H4
Yao, L2
Sun, L3
Zhu, Z1
Naren, N1
Zhang, XX2
Gentile, GL1
Rupert, AS1
Carrasco, LI1
Garcia, EM1
Kumar, NG1
Walsh, SW1
Jefferson, KK1
Guest, RL1
Samé Guerra, D1
Wissler, M1
Grimm, J1
Silhavy, TJ1
Lee, JH2
Yoo, JS1
Kim, Y1
Kim, JS2
Lee, EJ1
Roe, JH1
Delorme, M1
Bouchard, PA1
Simon, M1
Simard, S1
Lellouche, F1
D'Urzo, KA1
Mok, F1
D'Urzo, AD1
Koneru, B1
Lopez, G1
Farooqi, A1
Conkrite, KL1
Nguyen, TH1
Macha, SJ1
Modi, A1
Rokita, JL1
Urias, E1
Hindle, A1
Davidson, H1
Mccoy, K1
Nance, J1
Yazdani, V1
Irwin, MS1
Yang, S1
Wheeler, DA1
Maris, JM1
Diskin, SJ1
Reynolds, CP1
Abhilash, L1
Kalliyil, A1
Sheeba, V1
Hartley, AM2
Meunier, B2
Pinotsis, N1
Maréchal, A2
Xu, JY1
Genko, N1
Haraux, F1
Rich, PR1
Kamalanathan, M1
Doyle, SM1
Xu, C1
Achberger, AM1
Wade, TL1
Schwehr, K1
Santschi, PH1
Sylvan, JB1
Quigg, A1
Leong, W1
Xu, W2
Gao, S1
Zhai, X1
Wang, C2
Gilson, E1
Ye, J1
Lu, Y1
Yan, R1
Zhang, Y6
Hu, Z1
You, Q1
Cai, Q1
Yang, D1
Gu, S1
Dai, H1
Zhao, X1
Gui, C1
Gui, J1
Wu, PK1
Hong, SK1
Starenki, D1
Oshima, K1
Shao, H1
Gestwicki, JE1
Tsai, S1
Park, JI1
Wang, Y7
Zhao, R1
Gu, Z1
Dong, C2
Guo, G1
Li, L4
Barrett, HE1
Meester, EJ1
van Gaalen, K1
van der Heiden, K1
Krenning, BJ1
Beekman, FJ1
de Blois, E1
de Swart, J1
Verhagen, HJ1
Maina, T1
Nock, BA1
Norenberg, JP1
de Jong, M1
Gijsen, FJH1
Bernsen, MR1
Martínez-Milla, J1
Galán-Arriola, C1
Carnero, M1
Cobiella, J1
Pérez-Camargo, D1
Bautista-Hernández, V1
Rigol, M1
Solanes, N1
Villena-Gutierrez, R1
Lobo, M1
Mateo, J1
Vilchez-Tschischke, JP1
Salinas, B1
Cussó, L1
López, GJ1
Fuster, V1
Desco, M1
Sanchez-González, J1
Ibanez, B1
van den Berg, P1
Schweitzer, DH1
van Haard, PMM1
Geusens, PP1
van den Bergh, JP1
Zhu, X1
Huang, X2
Xu, H2
Yang, G2
Lin, Z1
Salem, HF1
Nafady, MM1
Kharshoum, RM1
Abd El-Ghafar, OA1
Farouk, HO1
Domiciano, D1
Nery, FC1
de Carvalho, PA1
Prudente, DO1
de Souza, LB1
Chalfun-Júnior, A1
Paiva, R1
Marchiori, PER1
Lu, M2
An, Z1
Jiang, J2
Li, J7
Du, S1
Zhou, H1
Cui, J1
Wu, W1
Liu, Y7
Song, J1
Lian, Q1
Uddin Ahmad, Z1
Gang, DD1
Konggidinata, MI1
Gallo, AA1
Zappi, ME1
Yang, TWW1
Johari, Y1
Burton, PR1
Earnest, A1
Shaw, K1
Hare, JL1
Brown, WA1
Kim, GA1
Han, S1
Choi, GH1
Choi, J1
Lim, YS1
Gallo, A1
Cancelli, C1
Ceron, E1
Covino, M1
Capoluongo, E1
Pocino, K1
Ianiro, G1
Cammarota, G1
Gasbarrini, A1
Montalto, M1
Somasundar, Y1
Lu, IC1
Mills, MR1
Qian, LY1
Olivares, X1
Ryabov, AD1
Collins, TJ1
Zhao, L1
Doddipatla, S1
Thomas, AM1
Nikolayev, AA1
Galimova, GR1
Azyazov, VN1
Mebel, AM1
Kaiser, RI1
Guo, S1
Yang, P1
Yu, X2
Wu, Y2
Zhang, H1
Yu, B2
Han, B1
George, MW1
Moor, MB1
Bonny, O1
Langenberg, E1
Paik, H1
Smith, EH1
Nair, HP1
Hanke, I1
Ganschow, S1
Catalan, G1
Domingo, N1
Schlom, DG1
Assefa, MK1
Wu, G2
Hayton, TW1
Becker, B1
Enikeev, D1
Netsch, C1
Gross, AJ1
Laukhtina, E1
Glybochko, P1
Rapoport, L1
Herrmann, TRW1
Taratkin, M1
Dai, W1
Shi, J2
Carreno, J1
Kloner, RA1
Pickersgill, NA1
Vetter, JM1
Kim, EH1
Cope, SJ1
Du, K1
Venkatesh, R1
Giardina, JD1
Saad, NES1
Bhayani, SB1
Figenshau, RS1
Eriksson, J1
Landfeldt, E1
Ireland, S1
Jackson, C1
Wyatt, E1
Gaudig, M1
Stancill, JS1
Happ, JT1
Broniowska, KA1
Hogg, N1
Corbett, JA1
Tang, LF1
Bi, YL1
Fan, Y2
Sun, YB1
Wang, AL1
Xiao, BH1
Wang, LF1
Qiu, SW1
Guo, SW1
Wáng, YXJ1
Sun, J2
Chu, S1
Pan, Q1
Li, D2
Zheng, S2
Ma, L1
Wang, L3
Hu, T1
Wang, F1
Han, Z1
Yin, Z1
Ge, X1
Xie, K1
Lei, P1
Dias-Santagata, D1
Lennerz, JK1
Sadow, PM1
Frazier, RP1
Govinda Raju, S1
Henry, D1
Chung, T1
Kherani, J1
Rothenberg, SM1
Wirth, LJ1
Marti, CN1
Choi, NG1
Bae, SJ1
Ni, L1
Luo, X1
Dai, T1
Yang, Y3
Lee, R1
Fleischer, AS1
Wemhoff, AP1
Ford, CR1
Kleppinger, EL1
Helms, K1
Bush, AA1
Luna-Abanto, J1
García Ruiz, L1
Laura Martinez, J1
Álvarez Larraondo, M1
Villoslada Terrones, V1
Dukic, L1
Maric, N1
Simundic, AM1
Chogtu, B1
Ommurugan, B1
Thomson, SR1
Kalthur, SG1
Benidir, M1
El Massoudi, S1
El Ghadraoui, L1
Lazraq, A1
Benjelloun, M1
Errachidi, F1
Cassar, M1
Law, AD1
Chow, ES1
Giebultowicz, JM1
Kretzschmar, D1
Salonurmi, T1
Nabil, H1
Ronkainen, J1
Hyötyläinen, T1
Hautajärvi, H1
Savolainen, MJ1
Tolonen, A1
Orešič, M1
Känsäkoski, P1
Rysä, J1
Hakkola, J1
Hukkanen, J1
Zhu, N1
Li, Y4
Du, Q1
Hao, P1
Cao, X1
Li, CX1
Zhao, S1
Luo, XM1
Feng, JX1
Gonzalez-Cotto, M1
Guo, L1
Karwan, M1
Sen, SK1
Barb, J1
Collado, CJ1
Elloumi, F1
Palmieri, EM1
Boelte, K1
Kolodgie, FD1
Finn, AV1
Biesecker, LG1
McVicar, DW1
Qu, F1
Deng, Z1
Xie, Y2
Tang, J3
Chen, Z2
Luo, W1
Xiong, D1
Zhao, D1
Fang, J1
Zhou, Z1
Niu, PP1
Song, B1
Xu, YM1
Zhang, Z2
Qiu, N1
Yin, J1
Zhang, J3
Guo, W1
Liu, M2
Liu, T2
Chen, D5
Luo, K1
He, Z2
Zheng, G1
Xu, F1
Sun, W1
Yin, F1
van Hest, JCM1
Du, L2
Shi, X1
Kang, S1
Duan, W1
Zhang, S2
Feng, J2
Qi, N1
Shen, G1
Ren, H1
Shang, Q1
Zhao, W2
Yang, Z2
Jiang, X2
Alame, M1
Cornillot, E1
Cacheux, V1
Tosato, G1
Four, M1
De Oliveira, L1
Gofflot, S1
Delvenne, P1
Turtoi, E1
Cabello-Aguilar, S1
Nishiyama, M1
Turtoi, A1
Costes-Martineau, V1
Colinge, J1
Guo, Q1
Quan, M1
Dong, J1
Bai, J1
Han, R1
Cai, Y1
Lv, YQ1
Chen, Q1
Lyu, HD1
Deng, L1
Zhou, D1
Xiao, X1
De Langhe, S1
Billadeau, DD1
Lou, Z1
Zhang, JS1
Xue, Z1
Shen, XD1
Gao, F1
Busuttil, RW1
Kupiec-Weglinski, JW1
Ji, H1
Otano, I1
Alvarez, M1
Minute, L1
Ochoa, MC1
Migueliz, I1
Molina, C1
Azpilikueta, A1
de Andrea, CE1
Etxeberria, I1
Sanmamed, MF1
Teijeira, Á1
Berraondo, P1
Melero, I1
Zhong, Z1
Xie, X1
Yu, Q1
Zhou, C2
Liu, C2
Liu, W1
Chen, W1
Yin, Y1
Li, CW1
Hsu, JL1
Zhou, Q1
Hu, B1
Fu, P1
Atyah, M1
Ma, Q2
Xu, Y1
Dong, Q1
Hung, MC1
Ren, N1
Huang, P1
Liao, R1
Chen, X4
Cao, Q1
Yuan, X1
Nie, W1
Yang, J2
Shao, B1
Ma, X1
Bi, Z1
Liang, X1
Tie, Y1
Mo, F1
Xie, D1
Wei, Y1
Wei, X2
Dokla, EME1
Fang, CS1
Chu, PC1
Chang, CS1
Abouzid, KAM1
Chen, CS1
Blaszczyk, R1
Brzezinska, J1
Dymek, B1
Stanczak, PS1
Mazurkiewicz, M1
Olczak, J1
Nowicka, J1
Dzwonek, K1
Zagozdzon, A1
Golab, J1
Golebiowski, A1
Xin, Z1
Himmelbauer, MK1
Jones, JH1
Enyedy, I1
Gilfillan, R1
Hesson, T1
King, K1
Marcotte, DJ1
Murugan, P1
Santoro, JC1
Gonzalez-Lopez de Turiso, F1
Pedron, J1
Boudot, C1
Brossas, JY1
Pinault, E1
Bourgeade-Delmas, S1
Sournia-Saquet, A1
Boutet-Robinet, E1
Destere, A1
Tronnet, A1
Bergé, J1
Bonduelle, C1
Deraeve, C1
Pratviel, G1
Stigliani, JL1
Paris, L1
Mazier, D1
Corvaisier, S1
Since, M1
Malzert-Fréon, A1
Wyllie, S1
Milne, R1
Fairlamb, AH1
Valentin, A1
Courtioux, B1
Verhaeghe, P1
Fang, X1
Gao, M1
Gao, H1
Bi, W1
Tang, H1
Cui, Y1
Zhang, L3
Fan, H1
Yu, H1
Mathison, CJN1
Chianelli, D1
Rucker, PV1
Nelson, J1
Roland, J1
Huang, Z2
Xie, YF1
Epple, R1
Bursulaya, B1
Lee, C1
Gao, MY1
Shaffer, J1
Briones, S1
Sarkisova, Y1
Galkin, A1
Li, N1
Li, C2
Hua, S1
Kasibhatla, S1
Kinyamu-Akunda, J1
Kikkawa, R1
Molteni, V1
Tellew, JE1
Jin, X1
Pang, B1
Liu, Q2
Liu, X3
Huang, Y2
Josephine Fauci, A1
Ma, Y1
Soo Lee, M1
Yuan, W1
Gao, R1
Qi, H1
Zheng, W1
Yang, F2
Chua, H1
Wang, K1
Ou, Y1
Huang, M1
Zhu, Y2
Yu, J1
Tian, J1
Zhao, M1
Hu, J1
Yao, C1
Zhang, B1
Usawachintachit, M1
Tzou, DT1
Washington, SL1
Hu, W1
Chi, T1
Sorensen, MD1
Bailey, MR1
Hsi, RS1
Cunitz, BW1
Simon, J1
Wang, YN1
Dunmire, BL1
Paun, M1
Starr, F1
Lu, W1
Evan, AP1
Harper, JD1
Han, G1
Rodrigues, AE1
Fouladvand, F1
Falahi, E1
Asbaghi, O1
Abbasnezhad, A1
Anigboro, AA1
Avwioroko, OJ1
Cholu, CO1
Sonei, A1
Fazelipour, S1
Kanaani, L1
Jahromy, MH1
Jo, K1
Hong, KB1
Suh, HJ1
Park, JH1
Shin, E1
Park, E1
Kouakou-Kouamé, CA1
N'guessan, FK1
Montet, D1
Djè, MK1
Kim, GD1
González-Fernández, D1
Pons, EDC1
Rueda, D1
Sinisterra, OT1
Murillo, E1
Scott, ME1
Koski, KG1
Shete, PB1
Gonzales, R1
Ackerman, S1
Cattamanchi, A1
Handley, MA1
Li, XX1
Xiao, SZ1
Gu, FF1
He, WP1
Ni, YX1
Han, LZ1
Heffernan, JK1
Valgepea, K1
de Souza Pinto Lemgruber, R1
Casini, I1
Plan, M1
Tappel, R1
Simpson, SD1
Köpke, M1
Nielsen, LK1
Marcellin, E1
Cen, YK1
Lin, JG1
Wang, YL1
Wang, JY1
Liu, ZQ1
Zheng, YG1
Spirk, D1
Noll, S1
Burnier, M1
Rimoldi, S1
Noll, G1
Sudano, I1
Penzhorn, BL1
Oosthuizen, MC1
Kobos, LM1
Alqatani, S1
Ferreira, CR1
Aryal, UK1
Hedrick, V1
Sobreira, TJP1
Shannahan, JH1
Gale, P1
Singhroy, DN1
MacLean, E1
Kohli, M1
Lessem, E1
Branigan, D1
England, K1
Suleiman, K1
Drain, PK1
Ruhwald, M1
Schumacher, S1
Denkinger, CM1
Waning, B1
Van Gemert, W1
Pai, M1
Myers, RK1
Bonsu, JM1
Carey, ME1
Yerys, BE1
Mollen, CJ1
Curry, AE1
Douglas, TA1
Alinezhadbalalami, N1
Balani, N1
Schmelz, EM1
Davalos, RV1
Kamaldinov, T1
Erndt-Marino, J1
Levin, M1
Kaplan, DL1
Hahn, MS1
Heidarimoghadam, R1
Farmany, A1
Lee, JJ1
Kang, J1
Park, S1
Cho, JH1
Oh, S1
Park, DJ1
Perez-Maldonado, R1
Cho, JY1
Park, IH1
Kim, HB1
Song, M1
Mfarrej, B1
Jofra, T1
Morsiani, C1
Gagliani, N1
Fousteri, G1
Battaglia, M1
Giuliano, C1
Levinger, I1
Vogrin, S1
Neil, CJ1
Allen, JD1
Lv, Y1
Yuan, R1
Cai, B1
Bahrami, B1
Chowdhury, AH1
Yang, C2
Qiao, Q1
Liu, SF1
Zhang, WH1
Kolano, L1
Knappe, D1
Volke, D1
Sträter, N1
Hoffmann, R1
Coussens, M1
Calders, P1
Lapauw, B1
Celie, B1
Banica, T1
De Wandele, I1
Pacey, V1
Malfait, F1
Rombaut, L1
Vieira, D1
Angel, S1
Honjol, Y1
Gruenheid, S1
Gbureck, U1
Harvey, E1
Merle, G1
Seo, G1
Lee, G1
Kim, MJ1
Baek, SH1
Choi, M1
Ku, KB1
Lee, CS1
Jun, S1
Park, D1
Kim, HG1
Kim, SJ1
Lee, JO1
Kim, BT1
Park, EC1
Kim, SI1
Ende, M1
Kirkkala, T1
Loitzenbauer, M1
Talla, D1
Wildner, M1
Miletich, R1
Criado, A1
Lavela, P1
Tirado, JL1
Pérez-Vicente, C1
Kang, D1
Feng, D2
Fang, Z1
Wei, F1
De Clercq, E1
Pannecouque, C1
Zhan, P1
Guo, Y1
Shen, Y1
Wang, Q2
Kawazoe, Y1
Jena, P1
Sun, Z1
Li, Z2
Liang, H1
Xu, X1
Ma, G1
Huo, X1
Church, JS1
Chace-Donahue, F1
Blum, JL1
Ratner, JR1
Zelikoff, JT1
Schwartzer, JJ1
Fiseha, T1
Tamir, Z1
Yao, W1
Wang, P1
Mi, K1
Cheng, J1
Gu, C1
Huang, J2
Sun, HB1
Xing, WQ1
Liu, XB1
Zheng, Y1
Yang, SJ1
Wang, ZF1
Liu, SL1
Ba, YF1
Zhang, RX1
Liu, BX1
Fan, CC1
Chen, PN1
Liang, GH1
Yu, YK1
Wang, HR1
Li, HM1
Li, ZX1
Lalani, SS1
Anasir, MI1
Poh, CL1
Khan, IT1
Nadeem, M1
Imran, M1
Khalique, A1
Raspini, B1
Porri, D1
De Giuseppe, R1
Chieppa, M1
Liso, M1
Cerbo, RM1
Civardi, E1
Garofoli, F1
Monti, MC1
Vacca, M1
De Angelis, M1
Cena, H1
Kong, D1
Han, X1
Zhou, Y3
Xue, H1
Zhang, W1
Ruan, Z1
Li, S2
Noer, PR1
Kjaer-Sorensen, K1
Juhl, AK1
Goldstein, A1
Ke, C1
Oxvig, C1
Duan, C1
Kong, F1
Lin, S1
Wang, Z2
Bhattacharya, R1
Mazumder, D1
Yan, X1
Ma, C1
Tang, Y1
Kong, X1
Lu, J1
Zhang, M2
Vital-Jacome, M1
Cazares-Granillo, M1
Carrillo-Reyes, J1
Buitron, G1
Jacob, SI1
Douair, I1
Maron, L1
Ménard, G1
Rusjan, P1
Sabioni, P1
Di Ciano, P1
Mansouri, E1
Boileau, I1
Laveillé, A1
Capet, M1
Duvauchelle, T1
Schwartz, JC1
Robert, P1
Le Foll, B1
Xia, Y1
Chen, S1
Luo, M1
Wu, J1
Cai, S1
He, Y2
Garbacz, P1
Misiak, M1
Jackowski, K1
Yuan, Q1
Sherrell, PC1
Chen, J2
Bi, X1
Nutho, B1
Mahalapbutr, P1
Hengphasatporn, K1
Pattaranggoon, NC1
Simanon, N1
Shigeta, Y1
Hannongbua, S1
Rungrotmongkol, T1
Caffrey, PJ1
Kher, R1
Bian, K1
Delaney, S1
Xue, J1
Wu, P1
Xu, L1
Yuan, Y1
Luo, J1
Ye, S1
Ustriyana, P1
Wei, B1
Raee, E1
Hu, Y1
Wesdemiotis, C1
Sahai, N1
Kaur, A1
Nigam, K1
Srivastava, S1
Tyagi, A1
Dang, S1
Millar, JE1
Bartnikowski, N1
Passmore, MR1
Obonyo, NG1
Malfertheiner, MV1
von Bahr, V1
Redd, MA1
See Hoe, L1
Ki, KK1
Pedersen, S1
Boyle, AJ1
Baillie, JK1
Shekar, K1
Palpant, N1
Suen, JY1
Matthay, MA1
McAuley, DF1
Fraser, JF1
Settles, JA1
Gerety, GF1
Spaepen, E1
Suico, JG1
Child, CJ1
Oh, BL1
Lee, JS1
Lee, EY1
Lee, HY1
Yu, HG1
Leslie, I1
Boos, LA1
Larkin, J1
Pickering, L1
Lima, HK1
Vogel, K1
Hampel, D1
Wagner-Gillespie, M1
Fogleman, AD1
Ferraz, SL1
O'Connor, M1
Mazzucchelli, TG1
Kajiyama, H1
Suzuki, S1
Shimbo, A1
Utsumi, F1
Yoshikawa, N1
Kikkawa, F1
Javvaji, PK1
Dhali, A1
Francis, JR1
Kolte, AP1
Roy, SC1
Selvaraju, S1
Mech, A1
Sejian, V1
DeSilva, S1
Vaidya, SS1
Mao, C1
Akhatayeva, Z1
Cheng, H1
Zhang, G1
Jiang, F1
Meng, X1
Elnour, IE1
Lan, X1
Song, E1
Rohde, S1
Antonides, CFJ1
Muslem, R1
de Woestijne, PCV1
der Meulen, MHV1
Kraemer, US1
Dalinghaus, M1
Bogers, AJJC1
Pourmand, A1
Ghassemi, M1
Sumon, K1
Amini, SB1
Hood, C1
Sikka, N1
Duan, H1
Chen, WP1
Fan, M1
Wang, WP1
Yu, L1
Tan, SJ1
Xin, S1
Wan, LJ1
Guo, YG1
Tanda, S1
Gingl, K1
Ličbinský, R1
Hegrová, J1
Goessler, W1
Li, ZL1
Zhou, YL1
Yan, W1
Luo, L1
Su, ZZ1
Fan, MZ1
Wang, SR1
Zhao, WG1
Xu, D1
Hassan, HM1
Jiang, Z1
Bachmann, KF1
Haenggi, M1
Jakob, SM1
Takala, J1
Gattinoni, L1
Berger, D1
Bentley, RF1
Vecchiarelli, E1
Banks, L1
Gonçalves, PEO1
Thomas, SG1
Goodman, JM1
Mather, K1
Boachie, R1
Anini, Y1
Panahi, S1
Anderson, GH1
Luhovyy, BL1
Nafie, MS1
Arafa, K1
Sedky, NK1
Alakhdar, AA1
Arafa, RK1
Fan, S1
Hu, H1
Liang, J1
Hu, BC1
Wen, Z1
Hu, D1
Liu, YY1
Chu, Q1
Wu, MC1
Lu, X1
Wang, D1
Hu, M1
Shen, H1
Yao, M1
Dahlgren, RA1
Vysloužil, J1
Kulich, P1
Zeman, T1
Vaculovič, T1
Tvrdoňová, M1
Mikuška, P1
Večeřa, Z1
Stráská, J1
Moravec, P1
Balcar, VJ1
Šerý, O1
Qiao, L1
Xiong, X1
Peng, X1
Zheng, J1
Duan, J1
Xiao, W1
Zhou, HY1
Sui, ZY1
Zhao, FL1
Sun, YN1
Wang, HY1
Han, BH1
Jintao, X1
Shasha, Y1
Jincai, W1
Chunyan, L1
Mengya, Y1
Yongli, S1
Rasoanirina, BNV1
Lassoued, MA1
Miladi, K1
Razafindrakoto, Z1
Chaâbane-Banaoues, R1
Ramanitrahasimbola, D1
Cornet, M1
Sfar, S1
Liang, C1
Xing, Q1
Yi, JL1
Zhang, YQ1
Li, CY1
Tang, SJ1
Gao, C1
Sun, X1
Peng, M1
Sun, XF1
Zhang, T1
Shi, JH1
Liao, CX1
Gao, WJ1
Sun, LL1
Gao, Y1
Cao, WH1
Lyu, J1
Yu, CQ1
Wang, SF1
Pang, ZC1
Cong, LM1
Dong, Z1
Wu, F1
Wu, XP1
Jiang, GH1
Wang, XJ1
Wang, BY1
Li, LM1
Pan, L1
Wan, SP1
Yi, HWL1
He, HJ1
Yong, ZP1
Shan, GL1
Weng, TT1
Yan, SQ1
Gao, GP1
Wei, C1
Tao, FB1
Shao, ZH1
Yao, T1
Dong, S1
Shi, S1
Feng, YL1
Zhang, YW1
Wang, SP1
Shi, AX1
Operario, D1
Zhang, ZH1
Zhu, XF1
Zaller, N1
Gao, P1
Sun, YH1
Zhang, HB1
Sarasola, MP1
Vidal, A1
Speisky, D1
Aponte-López, A1
Fuentes-Pananá, EM1
Cortes-Muñoz, D1
Muñoz-Cruz, S1
Martinel Lamas, DJ3
Croci, M2
Carabajal, E1
Crescenti, EJ2
Sambuco, L2
Bergoc, RM2
Rivera, ES4
Porretti, JC1
Mohamad, NA2
Martín, GA2
Cricco, GP2
Cortina, JE1
Ventura, C1
Valli, E2
Balestrasse, KB1
Blanco, H1
Jakhar, R1
Paul, S1
Bhardwaj, M1
Kang, SC1
Galarza, TE1
Vedoya, GM1
He, YJ1
Xing, L1
Cui, PF1
Zhang, JL1
Qiao, JB1
Lyu, JY1
Luo, CQ1
Zhou, YX1
Lu, N1
Jiang, HL1
Kyriakidis, K1
Zampeli, E1
Tiligada, E1
Genre, F1
Medina, V3
Gutiérrez, A1
Rivera, E3
Cricco, G4
Martín, G3
von Mach-Szczypiński, J2
Stanosz, S2
Sieja, K2
Stanosz, M2
Brenet, O1
Lalourcey, L1
Queinnec, M1
Dupoiron, D1
Jayr, C1
Rosay, H1
Mavoungou, P1
Monnin, D1
Ancel, B1
Maget, B1
Louvier, N1
Malinovsky, JM1
HAKANSSON, R1
DOTEVALL, G1
WESTLING, H1
VANORDEN, LS1
VUGMAN, I1
GIARMAN, NJ1
Olewniczak, S1
Dewachter, P1
Mouton-Faivre, C1
Benhaijoub, A1
Abel-Decollogne, F1
Mertes, PM1
Nuñez, M2
Mohamad, N2
Correa-Fiz, F1
Sanchez-Jimenez, F2
Bergoc, R3
Vesuna, F1
Raman, V1
Crescenti, E1
Massari, N1
Cianchi, F1
Vinci, MC1
Masini, E1
Kosaka, A1
Wani, T1
Hattori, Y1
Yamashita, A1
Faverio, F1
Guzzetti, A1
Mereghetti, A1
Jemoli, R1
Garcia-Caballero, M2
Neugebauer, E2
Rodriguez, F2
Nuñez de Castro, I2
Vara-Thorbeck, C1
Davio, C1
Baldi, A1
Mladovan, A1
Fitzsimons, C1
Reynolds, JL1
Akhter, JA1
Magarey, CJ1
Schwartz, P2
Adams, WJ1
Morris, DL2
Chew, CS1
Parente, JA1
Baranco, E1
Bowrey, PF1
King, J1
Magarey, C1
Marr, P1
Bolton, E1
Peacock, EE1
Byar, DP1
Blackard, CE1
Bobro, LI1
Iakhimovich, LV1
Chernyĭ, VA1
Nekrasov, PIa1
Dorfman, VM1
Bousquet, J1
Pujol, JL1
Barneon, G1
Hejjaoui, A1
Nardoux, J1
Ausseil, M1
Godard, P1
Joyeux, H1
Michel, FB1
Heredia, A1
Oosting, E1
Vara Thorbeck, C1
Brandes, LJ1
Bogdanovic, RP1
Cawker, MD1
LaBella, FS1
Chanda, R1
Ganguly, AK1
White, MJ1
Miller, FN1
Heuser, LS1
Pietsch, CG1
Kharkevich, DD1
Polevaia, EB1
Field, EJ1
Caspary, EA1
Carnegie, PR1

Reviews

4 reviews available for histamine and Breast Cancer

ArticleYear
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
Mast Cell, the Neglected Member of the Tumor Microenvironment: Role in Breast Cancer.
    Journal of immunology research, 2018, Volume: 2018

    Topics: Animals; Biomarkers, Tumor; Breast Neoplasms; Female; Histamine; Humans; Mast Cells; Neovascularizat

2018
Histamine receptors and cancer pharmacology: an update.
    British journal of pharmacology, 2020, Volume: 177, Issue:3

    Topics: Breast Neoplasms; Female; Histamine; Humans; Ligands; Receptors, G-Protein-Coupled; Receptors, Hista

2020
Histamine H4 receptor: insights into a potential therapeutic target in breast cancer.
    Frontiers in bioscience (Scholar edition), 2015, 06-01, Volume: 7, Issue:1

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Female; Heterografts; Histamine; Histamine Antagon

2015

Trials

4 trials available for histamine and Breast Cancer

ArticleYear
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
[Effect of lentinan administration of adrenalectomized rats and patients with breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1982, Volume: 9, Issue:8

    Topics: Adrenalectomy; Animals; Breast Neoplasms; Capillary Permeability; Castration; Clinical Trials as Top

1982
Histamine, mast cells and tumour cell proliferation in breast cancer: does preoperative cimetidine administration have an effect?
    British journal of cancer, 2000, Volume: 82, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Cell Count; Cell Division; Cime

2000
Skin test reactivity in patients suffering from lung and breast cancer.
    The Journal of allergy and clinical immunology, 1991, Volume: 87, Issue:6

    Topics: Adult; Aged; Breast Neoplasms; Codeine; Female; Histamine; Humans; Lung Neoplasms; Mast Cells; Middl

1991

Other Studies

37 other studies available for histamine and Breast Cancer

ArticleYear
Anti-neoplastic action of Cimetidine/Vitamin C on histamine and the PI3K/AKT/mTOR pathway in Ehrlich breast cancer.
    Scientific reports, 2022, 07-07, Volume: 12, Issue:1

    Topics: Animals; Apoptosis; Ascorbic Acid; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cimetidin

2022
Intervention for Hepatic and Pulmonary Metastases in Breast Cancer Patients: Prospective, Multi-institutional Registry Study-IMET, Protocol MF 14-02.
    Annals of surgical oncology, 2022, Volume: 29, Issue:10

    Topics: Breast Neoplasms; Female; Histamine; Humans; Liver Neoplasms; Lung Neoplasms; Prognosis; Prospective

2022
Study of the antitumour effects and the modulation of immune response by histamine in breast cancer.
    British journal of cancer, 2020, Volume: 122, Issue:3

    Topics: Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Databases

2020
Impact of histamine H4 receptor deficiency on the modulation of T cells in a murine breast cancer model.
    Cancer immunology, immunotherapy : CII, 2021, Volume: 70, Issue:1

    Topics: Animals; Breast Neoplasms; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Disease Models, A

2021
Therapeutic potential of histamine H₄ receptor agonists in triple-negative human breast cancer experimental model.
    British journal of pharmacology, 2013, Volume: 170, Issue:1

    Topics: Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Clozapine; Disease Progression; Female; Gene

2013
Fibroblasts induce epithelial to mesenchymal transition in breast tumor cells which is prevented by fibroblasts treatment with histamine in high concentration.
    The international journal of biochemistry & cell biology, 2014, Volume: 51

    Topics: Breast Neoplasms; Cell Line, Tumor; Cell Movement; Disease Progression; Epithelial-Mesenchymal Trans

2014
Enhancement of ionizing radiation response by histamine in vitro and in vivo in human breast cancer.
    Cancer biology & therapy, 2015, Volume: 16, Issue:1

    Topics: Animals; Antioxidants; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cellular Senescence; Disease M

2015
Astemizole-Histamine induces Beclin-1-independent autophagy by targeting p53-dependent crosstalk between autophagy and apoptosis.
    Cancer letters, 2016, Mar-01, Volume: 372, Issue:1

    Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apo

2016
Histamine prevents radiation-induced mesenchymal changes in breast cancer cells.
    Pharmacological research, 2016, Volume: 111

    Topics: Antigens, CD; beta Catenin; Breast Neoplasms; Cadherins; Cell Movement; Dose-Response Relationship,

2016
Transferrin-inspired vehicles based on pH-responsive coordination bond to combat multidrug-resistant breast cancer.
    Biomaterials, 2017, Volume: 113

    Topics: Animals; Antibiotics, Antineoplastic; Breast; Breast Neoplasms; Cattle; Cell Line, Tumor; Delayed-Ac

2017
Histamine levels in whole peripheral blood from women with ductal breast cancer: a pilot study.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2009, Volume: 58 Suppl 1

    Topics: Animals; Breast Neoplasms; Carcinoma, Ductal; Female; Histamine; Humans; Pilot Projects

2009
Effect of histamine on the expression of metalloproteinases and cell adhesion in breast cancer cell lines.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2009, Volume: 58 Suppl 1

    Topics: Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Female; Histamine; Humans; Matrix Metalloproteina

2009
Histamine and its metabolizing enzymes in tissues of primary ductal breast cancer.
    European journal of gynaecological oncology, 2009, Volume: 30, Issue:5

    Topics: Adult; Aged; Breast Neoplasms; Carboxy-Lyases; Carcinoma, Ductal; Case-Control Studies; Female; Hist

2009
Hypersensitivity reactions to Patent Blue V in breast cancer surgery: a prospective multicentre study.
    Acta anaesthesiologica Scandinavica, 2013, Volume: 57, Issue:1

    Topics: Aged; Anesthesia, General; Breast Neoplasms; Coloring Agents; Drug Hypersensitivity; Female; France;

2013
Formation of histamine in transplants from a rat mammary carcinoma.
    Experientia, 1961, Sep-15, Volume: 17

    Topics: Animals; Breast; Breast Neoplasms; Carcinoma; Histamine; Humans; Rats; Transplants

1961
GASTRIC ACID SECRETION BEFORE AND AFTER HYPOPHYSECTOMY IN MAN.
    Acta medica Scandinavica, 1963, Volume: 174

    Topics: Breast Neoplasms; Cortisone; Diabetic Retinopathy; Gastric Acid; Gastric Juice; Histamine; Humans; H

1963
5-HYDROXYTRYPTAMINE IN SINGLE NEOPLASTIC MAST CELLS: A MICROSCOPIC SPECTROFLUOROMETRIC STUDY.
    Science (New York, N.Y.), 1965, Apr-30, Volume: 148, Issue:3670

    Topics: Animals; Breast Neoplasms; Catecholamines; Fluorescence; Fluorometry; Histamine; Humans; Mammary Neo

1965
Concentration of histamine in serum and tissues of the primary ductal breast cancers in women.
    Breast (Edinburgh, Scotland), 2005, Volume: 14, Issue:3

    Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Case-Control Studies; D-Amin

2005
Anaphylactic reaction to patent blue V after sentinel lymph node biopsy.
    Acta anaesthesiologica Scandinavica, 2006, Volume: 50, Issue:2

    Topics: Anaphylaxis; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Breast Neoplasms; Coloring Age

2006
Histamine-mediated signaling processes in human malignant mammary cells.
    Cancer biology & therapy, 2006, Volume: 5, Issue:11

    Topics: Apoptosis; Breast Neoplasms; Cell Cycle; Cell Division; Cell Line, Tumor; DNA Primers; Female; Hista

2006
Histamine: a potential therapeutic agent for breast cancer treatment?
    Cancer biology & therapy, 2006, Volume: 5, Issue:11

    Topics: Breast Neoplasms; Cell Line, Tumor; Female; Histamine; Humans; Signal Transduction

2006
The role of histamine in human mammary carcinogenesis: H3 and H4 receptors as potential therapeutic targets for breast cancer treatment.
    Cancer biology & therapy, 2008, Volume: 7, Issue:1

    Topics: Adult; Aged; Breast; Breast Neoplasms; Cell Movement; Cell Proliferation; Female; Histamine; Histidi

2008
Histamine in cancer: the dual faces of the coin.
    Cancer biology & therapy, 2008, Volume: 7, Issue:1

    Topics: Breast Neoplasms; Female; Histamine; Humans; Receptors, G-Protein-Coupled; Receptors, Histamine; Rec

2008
[Hyperhistaminemia in neoplasms of the breast].
    Chirurgia italiana, 1982, Volume: 34, Issue:5

    Topics: Adult; Aged; Breast Neoplasms; Cholecystectomy; Female; Histamine; Humans; Mastectomy; Middle Aged

1982
Histamine synthesis and content in benign and malignant breast tumours. Its effects on other host tissues.
    Surgical oncology, 1994, Volume: 3, Issue:3

    Topics: Breast; Breast Neoplasms; Histamine; Histidine Decarboxylase; Humans; Muscles; Skin

1994
Expression of histamine receptors in different cell lines derived from mammary gland and human breast carcinomas.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 1995, Volume: 44 Suppl 1

    Topics: Breast; Breast Neoplasms; Cell Line; Cell Transformation, Neoplastic; Epithelial Cells; Epithelium;

1995
Histamine in human breast cancer.
    The British journal of surgery, 1998, Volume: 85, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma; Dose-Response Relationship, Drug; Femal

1998
Lasp-1 is a regulated phosphoprotein within the cAMP signaling pathway in the gastric parietal cell.
    The American journal of physiology, 1998, Volume: 275, Issue:1

    Topics: Adaptor Proteins, Signal Transducing; Amino Acid Sequence; Animals; Base Sequence; Breast Neoplasms;

1998
Management of benign disease of the breast.
    The American surgeon, 1978, Volume: 44, Issue:10

    Topics: Breast; Breast Diseases; Breast Neoplasms; Cysts; Female; Histamine; Histamine H1 Antagonists; Hormo

1978
Letters: Rserpine and prostatic cancer.
    Urology, 1975, Volume: 5, Issue:1

    Topics: Animals; Breast Neoplasms; Carcinoma 256, Walker; Cell Transformation, Neoplastic; Dextrans; Drug Ev

1975
[Diagnostic analysis of biogenic amines in tumors].
    Arkhiv patologii, 1976, Volume: 38, Issue:9

    Topics: Adenofibroma; Biogenic Amines; Breast Neoplasms; Catecholamines; Female; Histamine; Humans; Lipoma;

1976
Changes in histamine synthesis, tissue content and catabolism in human breast cancer.
    Agents and actions, 1989, Volume: 27, Issue:1-2

    Topics: Adult; Aged; Breast; Breast Neoplasms; Female; Histamine; Histidine Decarboxylase; Humans; Methylhis

1989
Histamine and growth: interaction of antiestrogen binding site ligands with a novel histamine site that may be associated with calcium channels.
    Cancer research, 1987, Aug-01, Volume: 47, Issue:15

    Topics: Animals; Binding, Competitive; Breast Neoplasms; Calcium Channel Blockers; Cell Division; Cell Line;

1987
Diamineoxidase activity and tissue histamine content of human skin, breast and rectal carcinoma.
    Cancer letters, 1987, Volume: 34, Issue:2

    Topics: Adult; Amine Oxidase (Copper-Containing); Breast Neoplasms; Carcinoma; Female; Histamine; Histidine

1987
Human malignant ascites and histamine-induced protein leakage from the normal microcirculation.
    Microvascular research, 1988, Volume: 35, Issue:1

    Topics: Animals; Ascites; Bradykinin; Breast Neoplasms; Capillary Permeability; Complement C3; Complement C3

1988
[Histamine-receptor sensitivity of lymphocytes in patients with early and advanced stage breast cancer].
    Eksperimental'naia onkologiia, 1988, Volume: 10, Issue:1

    Topics: Breast Neoplasms; Cimetidine; Diphenhydramine; Female; Histamine; Humans; In Vitro Techniques; Leuko

1988
Lymphocyte sensitization to basic protein of brain in malignant neoplasia: experiments with serotonin and related compounds.
    Nature, 1971, Sep-24, Volume: 233, Issue:5317

    Topics: Acetylcholine; Adult; Brain; Brain Chemistry; Breast Neoplasms; Bronchial Neoplasms; Carcinoma; Cell

1971